ASND|Ascendis Pharma A/S|Preço:237.826|Var. %:-0.83

Mais detalhes de Ascendis Pharma A/S Empresa

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Informações de Ascendis Pharma A/S



Código da empresaASND

Nome da EmpresaAscendis Pharma A/S

Data de listagemJan 28, 2015

CEOMoller Mikkelsen (Jan)

Número de funcionários- -

Tipo de títulosDepository Receipt

Fim do ano fiscalJan 28

EndereçoTuborg Boulevard 12

CidadeHELLERUP

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísDenmark

Código postal2900

Telefone4570222244

Sitehttps://ascendispharma.dk/

Código da empresaASND

Data de listagemJan 28, 2015

CEOMoller Mikkelsen (Jan)

Executivos da empresa Ascendis Pharma A/S



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Flemming Steen Jensen

Executive Vice President, Product Supply and Quality

11.39K

--

Mr. Michael Wolff Jensen

Executive Vice President, Chief Legal Officer, Member of the Executive Board

5.76K

+66.49%

Mr. Lars Holtug, CPA

Independent Director

2.66K

+40.20%

Dr. Albert Cha, M.D., Ph.D.

Independent Chairman of the Board

2.16K

+49.63%

Ms. Siham Imani

Independent Director

1.10K

+66.82%

Mr. Jan Moller Mikkelsen

President, Chief Executive Officer, Executive Director, Member of the Executive Board

--

Ms. Lotte Soenderbjerg

Executive Vice President, Chief Administrative Officer, Member of the Executive Board

--

Dr. Kennett Sprogoee, Ph.D.

Executive Vice President, Head of Innovation and Research

--

Mr. Scott T. Smith

Chief Financial Officer, Executive Vice President, Member of the Executive Board

--

Ms. Lisa Bright

Independent Director

--

-100.00%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Flemming Steen Jensen

Executive Vice President, Product Supply and Quality

11.39K

--

Mr. Michael Wolff Jensen

Executive Vice President, Chief Legal Officer, Member of the Executive Board

5.76K

+66.49%

Mr. Lars Holtug, CPA

Independent Director

2.66K

+40.20%

Dr. Albert Cha, M.D., Ph.D.

Independent Chairman of the Board

2.16K

+49.63%

Ms. Siham Imani

Independent Director

1.10K

+66.82%

Mr. Jan Moller Mikkelsen

President, Chief Executive Officer, Executive Director, Member of the Executive Board

--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Commercial sale of products

683.57M

94.92%

Rendering of services

18.01M

2.50%

Milestones

12.92M

1.79%

License

5.63M

0.78%

Por RegiãoUSD

Nome

Receita

Proporção

North America

546.39M

75.87%

Europe

108.05M

15.00%

Rest of world

52.80M

7.33%

Denmark

12.90M

1.79%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Commercial sale of products

683.57M

94.92%

Rendering of services

18.01M

2.50%

Milestones

12.92M

1.79%

License

5.63M

0.78%

Distribuição de ações

Atualizado em: há 20 horas

Investidores

Tipos de investidores

Investidores

Proporção

RA Capital Management, LP

16.55%

Westfield Capital Management Company, L.P.

8.35%

Avoro Capital Advisors LLC

8.23%

Janus Henderson Investors

6.54%

Fidelity Management & Research Company LLC

6.12%

Outro

54.21%

Investidores

Proporção

RA Capital Management, LP

16.55%

Westfield Capital Management Company, L.P.

8.35%

Avoro Capital Advisors LLC

8.23%

Janus Henderson Investors

6.54%

Fidelity Management & Research Company LLC

6.12%

Outro

54.21%

Tipos de investidores

Investidores

Proporção

Investment Advisor/Hedge Fund

42.09%

Investment Advisor

40.09%

Venture Capital

16.77%

Hedge Fund

6.19%

Research Firm

3.18%

Private Equity

2.23%

Individual Investor

0.82%

Pension Fund

0.43%

Sovereign Wealth Fund

0.38%

Participação acionária institucional



Atualizado em: dom, 5 de abr

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2026Q1

582

69.20M

111.42%

-1.68M

2025Q4

523

68.62M

116.45%

+3.30K

2025Q3

540

68.73M

112.39%

+4.25M

2025Q2

515

64.43M

118.51%

-2.60M

2025Q1

495

67.05M

117.13%

-3.67M

2024Q4

471

65.26M

121.58%

+1.14M

2024Q3

461

64.02M

116.74%

+1.57M

2024Q2

446

62.31M

123.50%

-4.72K

2024Q1

440

62.32M

122.74%

-9.15M

2023Q4

415

61.74M

123.84%

-59.49K

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

RA Capital Management, LP

10.28M

16.59%

--

Dec 31, 2025

Westfield Capital Management Company, L.P.

5.19M

8.37%

-74.21K

-1.41%

Dec 31, 2025

Avoro Capital Advisors LLC

5.11M

8.25%

+1.11K

+0.02%

Dec 31, 2025

Janus Henderson Investors

4.06M

6.55%

-261.42K

-6.05%

Dec 31, 2025

Fidelity Management & Research Company LLC

3.80M

6.13%

-317.86K

-7.72%

Dec 31, 2025

Artisan Partners Limited Partnership

3.23M

5.2%

-495.00K

-13.30%

Dec 31, 2025

Capital International Investors

3.06M

4.94%

+3.33K

+0.11%

Dec 31, 2025

MFS Investment Management

1.88M

3.04%

+3.94K

+0.21%

Dec 31, 2025

Wellington Management Company, LLP

1.76M

2.84%

-36.21K

-2.01%

Dec 31, 2025

T. Rowe Price Investment Management, Inc.

1.67M

2.69%

-998.99K

-37.46%

Dec 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

Harbor Health Care ETF

17.71%

American Century Focused Dynamic Growth ETF

2.8%

AdvisorShares Dorsey Wright ADR ETF

2.62%

Virtus LifeSci Biotech Products ETF

1.89%

Tema Heart & Health ETF

1.45%

ProShares Ultra Nasdaq Biotechnology

1.2%

Invesco Nasdaq Biotechnology ETF

1.19%

First Trust Innovation Leaders ETF

1.18%

Putnam Sustainable Future ETF

1.11%

Main Thematic Innovation ETF

1.07%

Ver Mais

Harbor Health Care ETF

Proporção17.71%

American Century Focused Dynamic Growth ETF

Proporção2.8%

AdvisorShares Dorsey Wright ADR ETF

Proporção2.62%

Virtus LifeSci Biotech Products ETF

Proporção1.89%

Tema Heart & Health ETF

Proporção1.45%

ProShares Ultra Nasdaq Biotechnology

Proporção1.2%

Invesco Nasdaq Biotechnology ETF

Proporção1.19%

First Trust Innovation Leaders ETF

Proporção1.18%

Putnam Sustainable Future ETF

Proporção1.11%

Main Thematic Innovation ETF

Proporção1.07%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados